Cargando…
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!
BACKGROUND: The onset of coeliac disease (CD) in the first year of life is uncommon and the diagnosis can be challenging due to the suboptimal sensitivity of tissue transglutaminase antibodies (tTG) at this age and the many other possible causes of malabsorption in infants. Antibodies to deamidated...
Autores principales: | Arigliani, Michele, Rech Morassutti, Francesca, Fabris, Martina, Melli, Paola, Tonutti, Elio, Cogo, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553580/ https://www.ncbi.nlm.nih.gov/pubmed/28797308 http://dx.doi.org/10.1186/s13052-017-0392-6 |
Ejemplares similares
-
Isolated positive deamidated gliadin peptide‐IgG has limited diagnostic utility in coeliac disease
por: Vootukuru, Nikil, et al.
Publicado: (2022) -
Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies
por: Lau, Michelle S., et al.
Publicado: (2019) -
Allergenicity of Deamidated and/or Peptide-Bond-Hydrolyzed Wheat Gliadin by Transdermal Administration
por: Abe, Ryosuke, et al.
Publicado: (2020) -
Prevalence of Anti-deamidated Gliadin Peptide Antibodies in Asian Patients With Irritable Bowel Syndrome
por: Lu, Wei, et al.
Publicado: (2014) -
Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease
por: Diós, Ádám, et al.
Publicado: (2022)